183 related articles for article (PubMed ID: 8270604)
1. Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.
Möbus VJ; Asphal W; Knapstein PG; Kreienberg R
J Cancer Res Clin Oncol; 1993; 120(1-2):27-34. PubMed ID: 8270604
[TBL] [Abstract][Full Text] [Related]
2. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R; Morris A; Passas J; Bateman W
Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
[TBL] [Abstract][Full Text] [Related]
3. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
5. Effects of biological response modifiers on ovarian carcinoma cell lines.
Marth C; Helmberg M; Mayer I; Fuith LC; Daxenbichler G; Dapunt O
Anticancer Res; 1989; 9(2):461-7. PubMed ID: 2502063
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
7. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens.
Wroblewski JM; Bixby DL; Borowski C; Yannelli JR
Lung Cancer; 2001; 33(2-3):181-94. PubMed ID: 11551413
[TBL] [Abstract][Full Text] [Related]
9. Modulation of ovarian carcinoma OV632 antigen by interferons.
Marth C; Müller-Holzner E; Gaugg I; Daxenbichler G; Dapunt O
Oncology; 1992; 49(1):53-7. PubMed ID: 1542495
[TBL] [Abstract][Full Text] [Related]
10. Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines.
Boyer CM; Dawson DV; Neal SE; Winchell LF; Leslie DS; Ring D; Bast RC
Cancer Res; 1989 Jun; 49(11):2928-34. PubMed ID: 2497969
[TBL] [Abstract][Full Text] [Related]
11. Differences of reactivity to interferon gamma in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study.
Lizard G; Chignol MC; Chardonnet Y; Schmitt D
J Cancer Res Clin Oncol; 1996; 122(4):223-30. PubMed ID: 8601575
[TBL] [Abstract][Full Text] [Related]
12. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
13. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons.
Graham GM; Guarini L; Moulton TA; Datta S; Ferrone S; Giacomini P; Kerbel RS; Fisher PB
Cancer Immunol Immunother; 1991; 32(6):382-90. PubMed ID: 1672507
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus.
Bornstein J; Lahat N; Kinarty A; Revel M; Abramovici H; Shapiro S
Cancer; 1997 Mar; 79(5):924-34. PubMed ID: 9041155
[TBL] [Abstract][Full Text] [Related]
16. Direct IFNluence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells.
Yano T; Sugio K; Yamazaki K; Kase S; Yamaguchi M; Ondo K; Sugimachi K
Lung Cancer; 2000 Dec; 30(3):169-74. PubMed ID: 11137201
[TBL] [Abstract][Full Text] [Related]
17. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines.
Maas IW; Boven E; Pinedo HM; Schlüper HM; Haisma HJ
Int J Cancer; 1991 Jul; 48(5):749-56. PubMed ID: 1830034
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
Abril E; Mendez RE; García A; Serrano A; Cabrera T; Garrido F; Ruiz-Cabello F
Tissue Antigens; 1996 May; 47(5):391-8. PubMed ID: 8795139
[TBL] [Abstract][Full Text] [Related]
19. Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.
Iwasaki K; Rogers LR; Estes ML; Barna BP
Neurosurgery; 1993 Sep; 33(3):489-93; discussion 493-4. PubMed ID: 8413882
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
